Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 6.15% | 54.02 | 0.9% | $2353.35m | |
| JNJ | Johnson & Johnson | -0.62% | 159.25 | 0.7% | $1167.23m | |
| MRK | Merck & Co., Inc. | -3.83% | 79.13 | 0.7% | $1134.44m | |
| LLY | Eli Lilly & Co. | -0.57% | 260.50 | 1.1% | $694.38m | |
| BMY | Bristol-Myers Squibb Co. | -0.53% | 56.51 | 1.0% | $694.21m | |
| ABBV | AbbVie, Inc. | -1.80% | 116.53 | 1.9% | $669.66m | |
| AZN | AstraZeneca Plc | 0.43% | 56.58 | 1.0% | $278.35m | |
| GSK | GlaxoSmithKline Plc | -1.42% | 41.01 | 0.2% | $185.81m | |
| NVS | Novartis AG | -1.44% | 80.73 | 0.2% | $180.89m | |
| BFRI | Biofrontera, Inc. | 51.34% | 7.90 | 0.0% | $139.46m | |
| VTRS | Viatris, Inc. | -2.30% | 12.75 | 0.0% | $132.99m | |
| RGEN | Repligen Corp. | 5.21% | 286.01 | 6.7% | $112.80m | |
| RPRX | Royalty Pharma Plc | -0.45% | 41.89 | 0.1% | $106.76m | |
| DRNA | Dicerna Pharmaceuticals, Inc. | -0.03% | 37.99 | 0.3% | $106.72m | |
| NVO | Novo Nordisk A/S | -0.76% | 108.21 | 0.1% | $96.98m |
Company Profile
XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.